Dean Investment Associates’s Argan AGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,851
Closed -$940K 219
2024
Q2
$940K Sell
12,851
-86,512
-87% -$5.67M 0.13% 188
2024
Q1
$5.02M Buy
99,363
+12,308
+14% +$577K 0.69% 44
2023
Q4
$4.07M Sell
87,055
-2,407
-3% -$110K 0.58% 65
2023
Q3
$4.07M Sell
89,462
-607
-0.7% -$25.1K 0.67% 54
2023
Q2
$3.55M Sell
90,069
-55,195
-38% -$2.23M 0.58% 65
2023
Q1
$5.88M Sell
145,264
-11,800
-8% -$463K 0.94% 23
2022
Q4
$5.79M Buy
157,064
+31,097
+25% +$1.09M 0.99% 17
2022
Q3
$4.05M Buy
125,967
+11,757
+10% +$414K 0.83% 34
2022
Q2
$4.26M Buy
114,210
+10,765
+10% +$412K 0.83% 27
2022
Q1
$4.2M Buy
103,445
+4,722
+5% +$185K 0.75% 35
2021
Q4
$3.82M Buy
98,723
+12,815
+15% +$536K 0.67% 42
2021
Q3
$3.75M Buy
85,908
+6,603
+8% +$298K 0.71% 36
2021
Q2
$3.79M Buy
79,305
+5,374
+7% +$268K 0.7% 36
2021
Q1
$3.94M Sell
73,931
-4,445
-6% -$214K 0.74% 29
2020
Q4
$3.49M Buy
78,376
+19,841
+34% +$890K 0.72% 38
2020
Q3
$2.45M Sell
58,535
-12,824
-18% -$564K 0.59% 56
2020
Q2
$3.38M Sell
71,359
-105,147
-60% -$4.02M 0.81% 29
2020
Q1
$6.1M Buy
176,506
+17,991
+11% +$746K 1.31% 4
2019
Q4
$6.36M Buy
158,515
+24,280
+18% +$933K 1% 14
2019
Q3
$5.27M Buy
134,235
+51,275
+62% +$2.07M 0.77% 38
2019
Q2
$3.37M Sell
82,960
-19,645
-19% -$921K 0.48% 97
2019
Q1
$5.13M Sell
102,605
-22,745
-18% -$1.02M 0.74% 48
2018
Q4
$4.74M Buy
125,350
+5,440
+5% +$230K 0.75% 50
2018
Q3
$5.16M Buy
119,910
+26,650
+29% +$1.08M 0.72% 51
2018
Q2
$3.82M Buy
+93,260
New +$3.64M 0.56% 83
2016
Q1
Sell
-87,090
Closed -$2.82M 207
2015
Q4
$2.82M Buy
87,090
+34,175
+65% +$1.23M 0.62% 77
2015
Q3
$1.83M Buy
+52,915
New +$2.04M 0.41% 104

Other funds holding AGX

Dean Investment Associates's AGX Position: Q3 2024 in Review

Dean Investment Associates sold out of Argan (AGX) in Q3 2024, closing a stake of 12,851 shares — an estimated $940K sold.

Dean Investment Associates first reported a position in AGX in Q3 2015 and held it in 27 quarters. The position peaked at $6.36M in Q4 2019. 243 funds tracked by Wall St. Rank hold AGX as of Q3 2024.

  • Dean Investment Associates reported no remaining Argan position as of Q3 2024 after selling out during the quarter.
  • Dean Investment Associates sold 12,851 Argan shares in Q3 2024, an estimated $940K.
  • Dean Investment Associates first reported a position in Argan in Q3 2015 and held it in 27 quarters.
  • Dean Investment Associates's Argan position peaked at $6.36M in Q4 2019.
  • 243 funds tracked by Wall St. Rank held Argan as of Q3 2024.

Based on Dean Investment Associates's 13F filing for Q3 2024, filed 15 Nov 2024.